WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 574440
Description: WAY 629 hydrochloride is a 5-HT2C agonist that stimulates intracellular Ca2+ mobilization in CHO cells expressing human 5-HT2C receptors.
MedKoo Cat#: 574440
Name: WAY 629 hydrochloride
Chemical Formula: C15H19ClN2
Exact Mass: 262.1237
Molecular Weight: 262.78
Elemental Analysis: C, 68.56; H, 7.29; Cl, 13.49; N, 10.66
Synonym: WAY 629 hydrochloride, WAY 629 HCl
IUPAC/Chemical Name: 1,2,3,4,8,9,10,11-Octahydro[1,4]diazepino[6,7,1-jk]carbazole hydrochloride
InChi Key: PZXUJERSOFOWES-UHFFFAOYSA-N
InChi Code: InChI=1S/C15H18N2.ClH/c1-2-7-14-12(5-1)13-6-3-4-11-10-16-8-9-17(14)15(11)13;/h3-4,6,16H,1-2,5,7-10H2;1H
SMILES Code: [H]Cl.N1(CCNC2)C3=C(C4=C1C2=CC=C4)CCCC3
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 262.78 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1. Sabb et al (2004) Cycloalkyl[b][1,4]benzodiazepinoindoles are agonists at the human 5-HT2C receptor. Bioorg.Med.Chem.Lett. 14 2603 PMID: 15109661
2. Dunlop et al (2004) Identification of cycloalkyl[b][1,4]benzodiazepinoindoles as novel 5-HT2C receptor agonists. Fund.Clin.Pharmacol. 18 145